The Orphan Drug Designation (ODD) offers significant benefits to companies developing new investigational products targeting rare diseases – but navigating the nuances of eligibility and the application process can be complex. ?? Swipe to explore four things to keep in mind as you prepare your application. (Interested in receiving tailored guidance from an experienced regulatory consultant? Reach out to our team to see how PharPoint can support your needs.)
